AGTX (Agentix) Tariff Resilience Score: 7/10 (As of Jul. 10, 2026)


What is Agentix Tariff Resilience Score?

Agentix AGTX Tariff Resilience Score is 7 as of Jul. 10, 2026. The stock has 2 warning signs investors should review. Among 1,369 Biotechnology companies, Agentix ranks better than 90.36% on this metric.

Agentix has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

Agentix has Agentix Corp has a moderate tariff resilience due to its focus on domestic markets and ability to source materials locally, reducing exposure to international trade fluctuations.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Agentix might have Highly Resilient.


Agentix  (OTCPK:AGTX) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Agentix Tariff Resilience Score Related Terms


AGTX vs BZYR, ATXI, EMMA: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Agentix's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agentix Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Agentix's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Agentix's Tariff Resilience Score falls into.


What does a Tariff Resilience Score of 7 mean?
Agentix (AGTX) has a Tariff Resilience Score of 7 as of Jul. 10, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Agentix ranks #132 out of 1369 companies in the Biotechnology industry, placing it in the top 9.6%.
Is Agentix's Tariff Resilience Score too high?
Agentix's current Tariff Resilience Score is 7. The Biotechnology industry median Tariff Resilience Score is 4.00. Agentix's value of 7 is 75% above this industry median. Based on the distribution chart, Agentix ranks #132 out of 1369 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Agentix's Tariff Resilience Score compare to BZYR and ATXI?
According to the Biotechnology industry distribution chart, Agentix ranks #132 out of 1369 companies for Tariff Resilience Score. This places Agentix in the top 10% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Agentix's value of 7 is 75% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,369 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Agentix's current Tariff Resilience Score of 7 is 75% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agentix's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agentix stock overvalued right now?
Agentix (AGTX) has a current Tariff Resilience Score of 7. The current Tariff Resilience Score is 7 and 75% above the Biotechnology industry median of 4.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Agentix (AGTX), the current Tariff Resilience Score is 7 as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Agentix Business Description

Address 32932 Pacific Coast Highway, No. 14-254, Dana Point, CA, USA, 92629
Agentix Corp is a biotechnology company. Through its subsidiary, it is engaged in the development and commercialization of novel therapeutics to treat metabolic diseases, peripheral neuropathy, progressive lung disease, and ischemic reperfusion injury. Its principal business objective is to develop both science-driven synthetic and natural cannabinoid therapeutics that address unmet medical needs and continue to drive innovations in the endocannabinoid space. Its pipeline of drug candidates includes AGTX-2004, a CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus (T2DM), and AGTX-2003 a peripherally-acting CB1 receptor inverse agonist that has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver disease.